B+
Bull case
20%
Probability
Target price
$79.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
BTSG
BrightSpring Health ServicesCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$66.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$47.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-03
Recent news sentiment (30D)
+0.3
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+67.3
Score
AI commentary
Primary-source operating news is constructive, but recent coverage is largely secondary and the stock is down 15.95% over 30 days. Social and market-positioning data are unavailable, analyst revision data are insufficient, and the limited peer set reduces confidence in relative valuation; the negative deterministic return prior supports monitoring rather than chasing strength.
RankAlpha Sentiment Codex - 2026-09-03
Open full AI memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-07-31eventQ2 results and raised FY2026 guidanceMedium impact
The company reported Q2 revenue of $3.873 billion, up 23%, adjusted EBITDA of $206 million, up 44%, leverage of 2.15x, and increased FY2026 revenue and adjusted EBITDA guidance. Consensus surprise data is unavailable. [#SEC-8K-2026-07-31]
2026-09-30catalystSecondary-offering and insider-sale overhangHigh impact
The June secondary offering by KKR and management, together with reported Form 4 dispositions, may create near-term supply and sentiment pressure despite strong operating results. [#SEC-8K-2026-07-31] [#SEC-FORM4-2026-06-05]
2026-12-31catalystExecution against raised FY2026 targetsHigh impact
The raised outlook calls for $15.1-$15.425 billion of revenue and $820-$845 million of adjusted EBITDA, creating a measurable year-end execution checkpoint. [#SEC-8K-2026-07-31]
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-03 • Updated nightlySource: Internal modelMethodology